scorecardresearch
Follow Us:
Friday, February 26, 2021

India to supply Covid-19 vaccines to six key partner nations from tomorrow

Countries including Bhutan, Maldives, Bangladesh, Nepal, Myanmar and Seychelles will be the first recipient countries to get the vaccines in a phased manner keeping in view the domestic requirements.

By: Express Web Desk | New Delhi |
Updated: January 19, 2021 8:02:33 pm
Bhubaneswar: Workers unload from a plane the first consignment of Covishield vaccines, dispatched from Serum Institue of India. (PTI)

The Ministry of External Affairs (MEA) Tuesday announced that India will be supplying Covid-19 vaccines to its neighbouring and key partner countries from January 20.

Countries including Bhutan, Maldives, Bangladesh, Nepal, Myanmar and Seychelles will be the first recipient countries to get the vaccines in a phased manner keeping in view the domestic requirements.

India is also waiting for required regulatory clearances from Sri Lanka, Afghanistan and Mauritius.

In a statement, the MEA said India has received several requests for the supply of Indian-manufactured vaccines from neighbouring and key partner countries.

“This will be calibrated against domestic requirements and international demand and obligations, including under GAVI’s Covax facility to developing countries,” the ministry said.

The announcement comes hours after it was reported that the Maldives will become the first country to receive the Covid-19 vaccine (Covishield) from India. The consignment is set to land at 2 pm at Velana International Airport, Malé via an Air India flight.

“It reaffirms India’s reputation as the first responder in any emergency situation,” a source familiar with the development had said.

The Maldives is the largest Covid-19 assistance recipient in India’s neighbourhood including medicine supply, food supply, medical team, training and financial assistance of $250 million.

India has already rolled out a massive coronavirus vaccination drive under which two vaccines, Covishield and Covaxin, are being administered to frontline health workers across the country.

While Oxford-AstraZeneca’s Covishield is being manufactured by the Serum Institute, and the Covaxin is being produced by Bharat Biotech.

📣 The Indian Express is now on Telegram. Click here to join our channel (@indianexpress) and stay updated with the latest headlines

For all the latest India News, download Indian Express App.

0 Comment(s) *
* The moderation of comments is automated and not cleared manually by indianexpress.com.
Advertisement
Advertisement
Advertisement
Advertisement